Histone methylation by PRMT1 epigenetically suppresses IFN-γ-induced MHC-I expression in colorectal cancer by inhibiting STAT1 activation, leading to impaired CD8+ T cell-mediated immune responses [108]. The gene discussed is IFNG; the disease is colorectal cancer.